Literature DB >> 2022524

Radiation sensitivity of Copenhagen rat prostatic carcinoma (R3327-AT and R3327-MATLyLu).

B R Rao1, B J Slotman, A A Geldof, C A Perez.   

Abstract

The radiosensitivity of two variants of the Dunning Copenhagen rat prostatic tumor R3327 was investigated. The R3327-AT variant, which is a poorly differentiated anaplastic, fast-growing tumor, was irradiated both in vivo and in vitro. Following irradiation, monodispersed cells were plated in vitro and colonies were counted after 7 days. The survival curve of R3327-AT cells irradiated in vivo showed an initial shoulder (Dq-value 0.97 Gy), followed by two exponential parts. The D0-value for the first part of the curve (0-10 Gy) was 2.76 Gy and for the second part of the curve (greater than 10 gy) 9.05 Gy. Extrapolation of the second part of the curve to the Y-axis indicated that the proportion of more radioresistant cells was about 10%. The survival curve for R3327-AT cells irradiated in vitro also suggested the presence of a radioresistant subpopulation, although the proportion was lower (about 3%). This difference might be due to the presence of an hypoxic fraction in the tumors irradiated in vivo, but not in vitro. Tumor cells from the R3327 tumor variant metastatic to lymph nodes and lungs (R3327-MATLyLu), were irradiated in vitro. The radiation effect was evaluated by in vitro colony formation in agar and by in vivo lung colony assay. The colony formation in agar yielded a D0-value of 1.09 Gy. No radioresistant subpopulation was identified in this variant. A similar radiosensitivity was observed by the in vivo lung colony assay (D0 1.39 Gy). The mean inactivation dose calculated for R3327-AT cells (3.45 Gy) was significantly higher than for the metastatic variant (2.00 Gy).

Entities:  

Mesh:

Year:  1991        PMID: 2022524     DOI: 10.1016/0360-3016(91)90194-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  High dose rate radiation treatment of experimental intramuscular prostate carcinoma.

Authors:  Christina Skourou; P Jack Hoopes; Summer L Gibbs-Strauss; David J Gladstone; Rendall Strawbridge; Keith D Paulsen
Journal:  Int J Radiat Biol       Date:  2009-04       Impact factor: 2.694

2.  Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy.

Authors:  Vasu Tumati; Sanjeev Mathur; Kwang Song; Jer-Tsong Hsieh; Dawen Zhao; Masaya Takahashi; Timothy Dobin; Leah Gandee; Timothy D Solberg; Amyn A Habib; Debabrata Saha
Journal:  Int J Oncol       Date:  2013-03-19       Impact factor: 5.650

Review 3.  PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.

Authors:  Sebastian Zschaeck; Fabian Lohaus; Marcus Beck; Gregor Habl; Stephanie Kroeze; Constantinos Zamboglou; Stefan Alexander Koerber; Jürgen Debus; Tobias Hölscher; Peter Wust; Ute Ganswindt; Alexander D J Baur; Klaus Zöphel; Nikola Cihoric; Matthias Guckenberger; Stephanie E Combs; Anca Ligia Grosu; Pirus Ghadjar; Claus Belka
Journal:  Radiat Oncol       Date:  2018-05-11       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.